Experimental and clinical trials with BCG immunotherapy.
D000230:Adenocarcinoma / Q000628:therapy; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D000942:Antigens, Bacterial / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D005260:Female; D005354:Fibrosarcoma / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D008325:Mammary Neoplasms, Experimental / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D009163:Mycobacterium bovis / Q000276:immunology*; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy*; D009439:Neuraminidase / Q000627:therapeutic use; D051381:Rats; D014734:Vibrio cholerae / Q000201:enzymology
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D000995:Antitubercular Agents; D001500:BCG Vaccine; D009439:Neuraminidase